Xu Debin, Chen Yunmei, Yuan Chunlei, Zhang Shuyong, Peng Wei
Department of Thyroid and Neck Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People's Republic of China.
Department of Oral and Maxillofacial Surgery, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China,
Onco Targets Ther. 2019 Jan 18;12:647-656. doi: 10.2147/OTT.S188691. eCollection 2019.
Although increasing evidence has demonstrated important roles for long non-coding RNAs (lncRNAs) in cancer development, their functions in oral squamous cell carcinoma (OSCC) growth remain largely unknown. Therefore, we aimed to investigate the role of LINC00662 in OSCC.
The expression of LINC00662 in 61 OSCC tissues and four OSCC cell lines were detected by quantitative reverse-transcription polymerase chain reaction (qRT-PCR). Cell proliferation was detected using Cell Counting Kit-8 (CCK-8) and EdU staining methods. Migration and invasion abilities were analyzed using transwell and wound healing assay. Cell cycle distribution and apoptosis rate were evaluated by flow cytometry. Western blot method was performed to detect protein expression.
We found that the expression of LINC00662 was significantly increased in OSCC tissues, and a higher expression of LINC00662 was detected in larger tumor size, higher stage tumors and with lymph node metastasis. Moreover, overexpression of LINC00662 induced OSCC cell proliferation, increased migration and invasion abilities, and suppressed cell apoptosis. Knockdown of LINC00662 decreased the proliferation, migration, and invasion abilities of OSCC cell, and induced apoptosis. Furthermore, LINC00662 regulated the Wnt/β-catenin pathway.
Our data indicate that LINC00662 may represent a novel indicator of OSCC and may be a potential therapeutic target for diagnosis and therapy.
尽管越来越多的证据表明长链非编码RNA(lncRNAs)在癌症发展中发挥重要作用,但其在口腔鳞状细胞癌(OSCC)生长中的功能仍 largely未知。因此,我们旨在研究LINC00662在OSCC中的作用。
采用定量逆转录聚合酶链反应(qRT-PCR)检测61例OSCC组织和4种OSCC细胞系中LINC00662的表达。使用细胞计数试剂盒-8(CCK-8)和EdU染色法检测细胞增殖。采用Transwell和伤口愈合试验分析迁移和侵袭能力。通过流式细胞术评估细胞周期分布和凋亡率。采用蛋白质印迹法检测蛋白质表达。
我们发现LINC00662在OSCC组织中的表达显著增加,并且在肿瘤体积较大、分期较高和有淋巴结转移的肿瘤中检测到LINC00662的表达较高。此外,LINC00662的过表达诱导OSCC细胞增殖,增加迁移和侵袭能力,并抑制细胞凋亡。敲低LINC00662降低了OSCC细胞的增殖、迁移和侵袭能力,并诱导凋亡。此外,LINC00662调节Wnt/β-连环蛋白通路。
我们的数据表明,LINC00662可能是OSCC的一种新型指标,可能是诊断和治疗的潜在靶点。